Duncan Moore

Active Investor

Non Executive Director at GH Research plc

Edinburgh, Scotland

Duncan Moore, Non Executive Director at GH Research plc is an active investor based in Edinburgh, Scotland. This profile covers what Duncan Moore backs, at which stage, and how founders can reach out in 2026.

Dr. Duncan Moore serves as Partner at East West Capital Partners. He also serves as Executive Chairman at Lamellar Biomedical. He serves as Board Member at ASP Isotopes, GH Research, Cycle pharma, and Forward Pharma. He is an Angel Investor. He served as Senior Advisor at Hadean Ventures. He is currently a partner at East West Capital. He served as Deputy Chairman at Braidlock. Prior to that, he was a Managing Director at Morgan Stanley where he was the global head of healthcare research. During this time he led the equity market positioning of a number of major healthcare companies including Wellcome, Sulzer Medica, Almirall, and Grupo Rovi. He served as a Chairman at StepJockey. He trained as a biochemist at the University of Leeds and has a Ph.D. from the University of Cambridge. Whilst at Cambridge he co-founded a molecular diagnostics company with 2 colleagues. Following his move to the capital market in 1985, he was involved in setting up the bankInvest BioVenture funds and sat on the board of these funds until they were sold in 2009.

Investor type: Angel
Stages: Early Stage Venture
Invests in: Healthcare & BiotechBiotech & PharmaSaaS & EnterpriseIoT & Connected DevicesPropTech & Real EstateLegalTech
Location: Edinburgh, Scotland
Typical check: $500K
Past investments: 5

Notable investments

ASP Isotopes IncGH ResearchForward Pharma A/SMorgan StanleyStepJockey

How to reach Duncan Moore

Angels and operators like Duncan Moore reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Duncan Moore invest in?

Duncan Moore invests in Healthcare & Biotech, Biotech & Pharma, SaaS & Enterprise and IoT & Connected Devices, typically at Early Stage Venture. Match your sector and stage, then reach out with a personalized pitch.